Table 7.
Compounds | Sample (Amount) | Sample Preparation | Analytical Technique | Limits of Detection | Limits of Quantitation | Recovery (%) | Reference |
---|---|---|---|---|---|---|---|
Psilocin glucuronide and Psilocin | Urine (0.1mL) | Enzymatic hydrolyses (β-glucuronidase), alkaline hydrolyses (potassium hydroxide) acid hydrolysis (concentratedhydrochloric acid) and deproteinization (methanol) | LC-MS (ESI) and LC-MS/MS (ESI) | 0.5 μg/L | - | - | [138] |
Psilocin glucuronide | Serum (0.1mL) | Enzymatic hydrolysis (β-glucuronidase) and deproteinization (methanol) | LC-MS (ESI) and LC-MS/MS (ESI) | 0.5 μg/L | - | - | [139] |
Mescaline, DMT, Psilocin, Psilocybin and Salvinorin A | Hair (25 mg) | Hydrolysis (M3reagent) | UHPLC-MS/MS (ESI) | 0.01–0.02 μg/g | 0.03–0.05 μg/g | 79.6–97.4 | [67] |
Caption: ESI (electrospray ionization); LC (liquid chromatography); MS (mass spectrometry); MS/MS (tandem mass spectrometry); UHPLC (ultrahigh-performance liquid chromatography).